PERSANTIN Side Effects

7018963-7 | Anaphylactic Reaction, Dyspnoea, Nausea, Obstructive Airways Disorder, Swollen Tongue
on Sep 20, 2010 Female patient from , 67 years of age, was diagnosed with cerebrovascular accident and was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, dyspnoea, nausea (What is nausea?), obstructive airways disorder, swollen tongue. Persantin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6809599-9 | Cardiac Disorder
Patient was taking Persantin (View Usage). Patient had the following side effects: cardiac disorder on Jun 24, 2010 from Additional patient health information: Male patient , 64 years of age, . Persantin dosage: 400 Mg. Patient was hospitalized.

6552365-2 | Haemoptysis, Pneumonia, Pulmonary Haemorrhage
Adverse event was reported on Jan 22, 2010 by a Male patient taking Persantin (View Usage) (Dosage: 200 Mg) was diagnosed with hypertension, prophylaxis and. Location: , weighting 149.5 lb, After Persantin was administered, patient had the following side effects: haemoptysis, pneumonia (What is pneumonia?), pulmonary haemorrhage. During the same period patient was treated with SUTENT (150 Mg) (View Sutent Review and Sutent Label ), ASPIRIN (80 Mg) (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METOPROLOL (50 Mg) (View Metoprolol Review and Metoprolol Label ), NUTRIDRINK (400 Ml) (View Nutridrink Review and Nutridrink Label ). Patient was hospitalized.

6179453-7 | Asthenia, Bradycardia, Exercise Tolerance Decreased, Fatigue
on Apr 24, 2009 Female patient from , 80 years of age, was diagnosed with essential hypertension and was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bradycardia, exercise tolerance decreased, fatigue. Persantin dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), AMLODIPIN ACCORD (View Amlodipin Accord Review and Amlodipin Accord Label ). Patient was hospitalized.


6084624-4 | Angina Unstable, Myocardial Infarction
on Feb 13, 2009 Male patient from , 57 years of age, was treated with Persantin (View Usage). Patient had the following side effects: angina unstable, myocardial infarction. Persantin dosage: 400mg. Patient was hospitalized.

6057948-4 | Angina Unstable, Myocardial Infarction
Patient was taking Persantin (View Usage). After Persantin was administered, patient had the following side effects: angina unstable, myocardial infarction on Jan 22, 2009 from Additional patient health information: Male patient , 57 years of age, . Persantin dosage: 400mg. Patient was hospitalized.

5902237-9 | Menorrhagia
Adverse event was reported on Sep 22, 2008 by a Female patient taking Persantin (View Usage) (Dosage: 400mg) was diagnosed with cerebrovascular accident prophylaxis and. Location: , 48 years of age, Patient experienced the following unwanted or unexpected effects: menorrhagia. During the same period patient was treated with ASPIRIN (75mg) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5809253-6 | Headache, Myalgia, Pain
on Jul 07, 2008 Female patient from , 74 years of age, weighting 178.6 lb, was diagnosed with myocardial ischaemia and was treated with Persantin (View Usage). Patient had the following side effects: headache (What is headache?), myalgia, pain (What is pain?). Persantin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

5799092-7 | Cerebral Haemorrhage, Loss Of Consciousness
on Jul 01, 2008 Male patient from , 81 years of age, was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: cerebral haemorrhage, loss of consciousness. Persantin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5571999-5 | Balance Disorder, Headache, Migraine, Nausea, Vertigo
Patient was taking Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, headache (What is headache?), migraine (What is migraine?), nausea (What is nausea?), vertigo on Dec 18, 2007 from Additional patient health information: Female patient , 72 years of age, weighting 113.3 lb, was diagnosed with transient ischaemic attack, blood pressure increased, breast cancer (What is breast cancer?), blood cholesterol increased, migraine (What is migraine?) and. Persantin dosage: . During the same period patient was treated with BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), NOLVADEX (20mg 2x Daily) (View Nolvadex Review and Nolvadex Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SUMATRIPTAN SUCCINATE (View Sumatriptan Succinate Review and Sumatriptan Succinate Label ).

5558659-1 | Renal Failure Acute, Tubulointerstitial Nephritis
Adverse event was reported on Dec 11, 2007 by a Male patient taking Persantin (View Usage) (Dosage: ) was diagnosed with cerebrovascular accident and. Location: , weighting 165.3 lb, Patient had the following side effects: renal failure acute, tubulointerstitial nephritis. During the same period patient was treated with ASCAL (View Ascal Review and Ascal Label ).

5547625-8 | Oedema Peripheral
on Dec 04, 2007 Male patient from , weighting 165.3 lb, was diagnosed with transient ischaemic attack and was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: oedema peripheral. Persantin dosage: . During the same period patient was treated with ATEROSOL (View Aterosol Review and Aterosol Label ), TILDIEM XR (View Tildiem Xr Review and Tildiem Xr Label ), ACETYLCARDIO (View Acetylcardio Review and Acetylcardio Label ), ISOSORBIDEMONONITRAAT (View Isosorbidemononitraat Review and Isosorbidemononitraat Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5508265-X | Oesophageal Haemorrhage
on Oct 31, 2007 Female patient from JAPAN , 69 years of age, weighting 116.8 lb, was diagnosed with nephritis and was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal haemorrhage. Persantin dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ). Patient was hospitalized.

5504608-1 | Oesophageal Haemorrhage
Patient was taking Persantin (View Usage). Patient had the following side effects: oesophageal haemorrhage on Oct 26, 2007 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with nephritis and. Persantin dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5481222-8 | Abdominal Pain Upper, Angina Unstable, Arrhythmia, Bundle Branch Block Right, Chest Pain, Dyspnoea, Headache, Hypertensive Crisis
Adverse event was reported on Oct 01, 2007 by a Female patient taking Persantin (View Usage) (Dosage: ) was diagnosed with platelet aggregation inhibition, hypertension and. Location: COLOMBIA , 77 years of age, weighting 136.7 lb, After Persantin was administered, patient had the following side effects: abdominal pain upper, angina unstable, arrhythmia (What is arrhythmia?), bundle branch block right, chest pain (What is chest pain?), dyspnoea, headache (What is headache?), hypertensive crisis. During the same period patient was treated with ZELNORM (6 Mg, Unk) (View Zelnorm Review and Zelnorm Label ), CAPTOPRIL (50 Mg, Q8h) (View Captopril Review and Captopril Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), METOPROLOL TARTRATE (50 Mg/day) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

5464554-9 | Acute Myocardial Infarction
on Sep 19, 2007 Male patient from , 62 years of age, was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction. Persantin dosage: 200mg Twice A Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ). Patient was hospitalized.

5450851-X | Abdominal Pain Upper, Angina Unstable, Arrhythmia, Bundle Branch Block Right, Chest Pain, Dyspnoea, Headache, Hypertensive Crisis
on Sep 05, 2007 Female patient from COLOMBIA , 77 years of age, was diagnosed with platelet aggregation inhibition, hypertension and was treated with Persantin (View Usage). Patient had the following side effects: abdominal pain upper, angina unstable, arrhythmia (What is arrhythmia?), bundle branch block right, chest pain (What is chest pain?), dyspnoea, headache (What is headache?), hypertensive crisis. Persantin dosage: . During the same period patient was treated with ZELNORM (6 Mg, Unk) (View Zelnorm Review and Zelnorm Label ), CAPTOPRIL (50 Mg, Q8h) (View Captopril Review and Captopril Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), METOPROLOL SUCCINATE (50 Mg/day) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5332010-4 | Abdominal Pain Upper, Angina Unstable, Arrhythmia, Bundle Branch Block Right, Chest Pain, Dyspnoea, Headache, Hypertensive Crisis
Patient was taking Persantin (View Usage). After Persantin was administered, patient had the following side effects: abdominal pain upper, angina unstable, arrhythmia (What is arrhythmia?), bundle branch block right, chest pain (What is chest pain?), dyspnoea, headache (What is headache?), hypertensive crisis on May 14, 2007 from COLOMBIA Additional patient health information: Female patient , 77 years of age, was diagnosed with platelet aggregation inhibition, hypertension and. Persantin dosage: . During the same period patient was treated with ZELMAC (6 Mg, Unk) (View Zelmac Review and Zelmac Label ), CAPTOPRIL (50 Mg, Q8h) (View Captopril Review and Captopril Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), EUGLUCON (View Euglucon Review and Euglucon Label ), METOPROLOL SUCCINATE (50 Mg/day) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5318259-5 | Arrhythmia, Chest Pain
Adverse event was reported on Apr 26, 2007 by a Female patient taking Persantin (View Usage) (Dosage: ) . Location: COLOMBIA , 77 years of age, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), chest pain (What is chest pain?). During the same period patient was treated with ZELMAC (6 Mg, Unk) (View Zelmac Review and Zelmac Label ).

5296575-3 | Liver Disorder
on Apr 10, 2007 Female patient from JAPAN , weighting 22.05 lb, was diagnosed with kawasaki's disease and was treated with Persantin (View Usage). Patient had the following side effects: liver disorder. Persantin dosage: . During the same period patient was treated with PERIACTIN (View Periactin Review and Periactin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5291260-6 | Blood Pressure Decreased, Overdose, Tachycardia
on Apr 05, 2007 Female patient from JAPAN , 20 years of age, was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: blood pressure decreased, overdose, tachycardia. Persantin dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ).

5283801-X | Liver Disorder
Patient was taking Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder on Mar 28, 2007 from JAPAN Additional patient health information: Female patient , weighting 22.05 lb, was diagnosed with kawasaki's disease and. Persantin dosage: . During the same period patient was treated with PERIACTIN (View Periactin Review and Periactin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5276211-2 | Overdose, Suicide Attempt
Adverse event was reported on Mar 23, 2007 by a Female patient taking Persantin (View Usage) (Dosage: ) . Location: JAPAN , 91 years of age, Patient had the following side effects: overdose, suicide attempt.

5265504-0 | Liver Disorder
on Mar 12, 2007 Female patient from JAPAN , weighting 22.05 lb, was diagnosed with kawasaki's disease and was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: liver disorder. Persantin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PERIACTIN (View Periactin Review and Periactin Label ).

4973372-7 | Gastric Haemorrhage, Gastric Mucosal Lesion
on Apr 10, 2006 Male patient from , 84 years of age, was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: gastric haemorrhage, gastric mucosal lesion. Persantin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), NORPRAMIN (View Norpramin Review and Norpramin Label ), MIOL (View Miol Review and Miol Label ), DITENSOR (View Ditensor Review and Ditensor Label ), EULEXIN (View Eulexin Review and Eulexin Label ), GELOCATIL (View Gelocatil Review and Gelocatil Label ), ALMAX (View Almax Review and Almax Label ). Patient was hospitalized.

4973371-5 | Duodenal Ulcer Haemorrhage
Patient was taking Persantin (View Usage). Patient had the following side effects: duodenal ulcer haemorrhage on Apr 10, 2006 from Additional patient health information: Male patient , 74 years of age, . Persantin dosage: . During the same period patient was treated with ALMAX (View Almax Review and Almax Label ), DUPHALAC (View Duphalac Review and Duphalac Label ), ADALGUR (200 Mg Glafenina, 2 Mg Tiocolchicosido) (View Adalgur Review and Adalgur Label ). Patient was hospitalized.

4973365-X | Duodenal Ulcer Haemorrhage, Erosive Duodenitis, Gastric Ulcer Haemorrhage
Adverse event was reported on Apr 10, 2006 by a Female patient taking Persantin (View Usage) (Dosage: ) . Location: , 83 years of age, After Persantin was administered, patient had the following side effects: duodenal ulcer haemorrhage, erosive duodenitis, gastric ulcer haemorrhage. During the same period patient was treated with GELOCATIL (View Gelocatil Review and Gelocatil Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), ORFIDAL (View Orfidal Review and Orfidal Label ), RANUBER (View Ranuber Review and Ranuber Label ).

4973364-8 | Upper Gastrointestinal Haemorrhage
on Apr 10, 2006 Male patient from , 60 years of age, was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: upper gastrointestinal haemorrhage. Persantin dosage: . During the same period patient was treated with ADIRO (View Adiro Review and Adiro Label ), CO DIOVAN (12,5 Mg Hydrochlorothiazide/80 Mg Valsartan) (View Co Diovan Review and Co Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

4973363-6 | Upper Gastrointestinal Haemorrhage
on Apr 10, 2006 Male patient from , 82 years of age, was diagnosed with diabetes mellitus and was treated with Persantin (View Usage). Patient had the following side effects: upper gastrointestinal haemorrhage. Persantin dosage: . During the same period patient was treated with LEXATIN (View Lexatin Review and Lexatin Label ), ECAZIDE (50 Mg Captopril/25 Mg Hydrochlorothiazide) (View Ecazide Review and Ecazide Label ), ASTUDAL (View Astudal Review and Astudal Label ), INSULINA MIXTARD HUMANA (288 Iu Insulin, 672 Iu Insulin Isofanica) (View Insulina Mixtard Humana Review and Insulina Mixtard Humana Label ). Patient was hospitalized.

4973362-4 | Duodenal Ulcer Haemorrhage
Patient was taking Persantin (View Usage). After Persantin was administered, patient had the following side effects: duodenal ulcer haemorrhage on Apr 10, 2006 from Additional patient health information: Male patient , 82 years of age, . Persantin dosage: . During the same period patient was treated with CYCLADOL (View Cycladol Review and Cycladol Label ), TEBETANE COMPUESTO (300 Mg Alanine/135 Mg Glycine/795 Mg Glutamic Acid/90 Mg Prunus Africana) (View Tebetane Compuesto Review and Tebetane Compuesto Label ), ZAMENE (View Zamene Review and Zamene Label ), ANDROCUR (View Androcur Review and Androcur Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), SERMION (View Sermion Review and Sermion Label ), RANITIDINA NORMON (View Ranitidina Normon Review and Ranitidina Normon Label ). Patient was hospitalized.

4973355-7 | Cardiac Failure, Duodenal Ulcer Haemorrhage, Helicobacter Pylori Identification Test Positive
Adverse event was reported on Apr 10, 2006 by a Male patient taking Persantin (View Usage) (Dosage: ) . Location: , 71 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure, duodenal ulcer haemorrhage, helicobacter pylori identification test positive. During the same period patient was treated with SEGURIL (View Seguril Review and Seguril Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

4973354-5 | Cardiac Failure, Gastric Mucosal Lesion, Haemorrhage
on Apr 10, 2006 Male patient from , 67 years of age, was treated with Persantin (View Usage). Patient had the following side effects: cardiac failure, gastric mucosal lesion, haemorrhage. Persantin dosage: . During the same period patient was treated with NOCTAMID (View Noctamid Review and Noctamid Label ), LANTANON (View Lantanon Review and Lantanon Label ), ORFIDAL (View Orfidal Review and Orfidal Label ), DOBUPAL (View Dobupal Review and Dobupal Label ). Patient was hospitalized.

4973348-X | Gastric Ulcer Haemorrhage, Helicobacter Pylori Identification Test Positive
on Apr 10, 2006 Male patient from , 70 years of age, was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: gastric ulcer haemorrhage, helicobacter pylori identification test positive. Persantin dosage: . During the same period patient was treated with CORALEN (View Coralen Review and Coralen Label ), LIPLAT (View Liplat Review and Liplat Label ), GELOCATIL (View Gelocatil Review and Gelocatil Label ). Patient was hospitalized.

4973347-8 | Gastric Ulcer Haemorrhage
Patient was taking Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer haemorrhage on Apr 10, 2006 from Additional patient health information: Male patient , 63 years of age, . Persantin dosage: . During the same period patient was treated with NITRODERM (View Nitroderm Review and Nitroderm Label ), ALMAX (View Almax Review and Almax Label ). Patient was hospitalized.

4973343-0 | Gastric Ulcer Haemorrhage
Adverse event was reported on Apr 10, 2006 by a Male patient taking Persantin (View Usage) (Dosage: ) . Location: , 86 years of age, Patient had the following side effects: gastric ulcer haemorrhage. During the same period patient was treated with ADIRO (View Adiro Review and Adiro Label ). Patient was hospitalized.

4969655-7 | Blood Creatinine Increased, Cerebral Haemorrhage, Headache, Hemiparesis
on Apr 04, 2006 Male patient from , 66 years of age, was diagnosed with thrombosis prophylaxis and was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: blood creatinine increased, cerebral haemorrhage, headache (What is headache?), hemiparesis. Persantin dosage: . During the same period patient was treated with TROMBYL (View Trombyl Review and Trombyl Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), NEXIUM (View Nexium Review and Nexium Label ), TRYPTIZOL (View Tryptizol Review and Tryptizol Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NATRIUMBIKARBONAT (View Natriumbikarbonat Review and Natriumbikarbonat Label ), LASIX (View Lasix Review and Lasix Label ), CARDIZEM UNOTARD (View Cardizem Unotard Review and Cardizem Unotard Label ). Patient was hospitalized.

4876964-9 | Convulsion, Opisthotonus, Spinal Cord Disorder
on Apr 22, 2005 Male patient from , 50 years of age, was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, opisthotonus, spinal cord disorder. Persantin dosage: . Patient was hospitalized.

4835115-7 | Acidosis, Cardiogenic Shock, Circulatory Collapse, Syncope
Patient was taking Persantin (View Usage). Patient had the following side effects: acidosis, cardiogenic shock, circulatory collapse, syncope on Dec 15, 2003 from Additional patient health information: Male patient , 78 years of age, was diagnosed with transient ischaemic attack and. Persantin dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), TROMBYL (View Trombyl Review and Trombyl Label ), ZINNAT (View Zinnat Review and Zinnat Label ).

4798119-9 | Alcohol Use, Suicide Attempt
Adverse event was reported on Oct 10, 2005 by a Male patient taking Persantin (View Usage) (Dosage: ) . Location: , weighting 176.4 lb, After Persantin was administered, patient had the following side effects: alcohol use, suicide attempt. During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), BAYMYCARD (View Baymycard Review and Baymycard Label ), EUPHYLLIN (View Euphyllin Review and Euphyllin Label ), EVINA (View Evina Review and Evina Label ), GODAMED (View Godamed Review and Godamed Label ), ISCOVER (View Iscover Review and Iscover Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), UNIPHYLLIN RETARDTABLETTEN (View Uniphyllin Retardtabletten Review and Uniphyllin Retardtabletten Label ). Patient was hospitalized.

4764285-4 | Ascites, Eosinophilia, Gastroenteritis Eosinophilic
on May 21, 2003 Female patient from JAPAN , weighting 103.6 lb, was diagnosed with arrhythmia (What is arrhythmia?), bronchitis chronic, osteoarthritis (What is osteoarthritis?) and was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, eosinophilia, gastroenteritis eosinophilic. Persantin dosage: . During the same period patient was treated with MUCOSOLVON (View Mucosolvon Review and Mucosolvon Label ), LOXONIN (View Loxonin Review and Loxonin Label ), GLUCOSAMINE (HEALTHY SUPPLEMENT FOOD) (View Glucosamine (healthy Supplement Food) Review and Glucosamine (healthy Supplement Food) Label ). Patient was hospitalized.

4653275-8 | Convulsion, Opisthotonus, Spinal Cord Disorder
on Apr 22, 2005 Male patient from , 50 years of age, was treated with Persantin (View Usage). Patient had the following side effects: convulsion, opisthotonus, spinal cord disorder. Persantin dosage: . Patient was hospitalized.

4613860-6 | Aptyalism, Oral Mucosa Atrophy, Tongue Atrophy
Patient was taking Persantin (View Usage). After Persantin was administered, patient had the following side effects: aptyalism, oral mucosa atrophy, tongue atrophy on Feb 28, 2005 from Additional patient health information: Female patient , 83 years of age, . Persantin dosage: 400 Mg (200 Mg, 1 In 12 Hr) Po.

4613860-6 | Aptyalism, Oral Mucosa Atrophy, Tongue Atrophy
Adverse event was reported on Feb 28, 2005 by a Female patient taking Persantin (View Usage) (Dosage: 400 Mg (200 Mg, 1 In 12 Hr) Po) . Location: , 83 years of age, Patient experienced the following unwanted or unexpected effects: aptyalism, oral mucosa atrophy, tongue atrophy.

4600647-3 | Diverticulitis Intestinal Haemorrhagic
on Feb 16, 2005 Male patient from , 87 years of age, was diagnosed with myocardial ischaemia, pain in extremity and was treated with Persantin (View Usage). Patient had the following side effects: diverticulitis intestinal haemorrhagic. Persantin dosage: Po. During the same period patient was treated with MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) (KA) (View Mexiletine Hydrochloride (mexiletine Hydrochloride) (ka) Review and Mexiletine Hydrochloride (mexiletine Hydrochloride) (ka) Label ). Patient was hospitalized.

4587940-8 | Diverticulitis Intestinal Haemorrhagic
on Feb 01, 2005 Male patient from , 87 years of age, was diagnosed with myocardial ischaemia and was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: diverticulitis intestinal haemorrhagic. Persantin dosage: Po. During the same period patient was treated with MEXILETINE HYDROCHLORIDE (View Mexiletine Hydrochloride Review and Mexiletine Hydrochloride Label ). Patient was hospitalized.

4567983-0 | Epistaxis
Patient was taking Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis on Jan 17, 2005 from Additional patient health information: Female patient , 82 years of age, was diagnosed with cerebrovascular accident and. Persantin dosage: 200mg Twice Po. During the same period patient was treated with ASPIRIN (75 Mg Once Daily Po) (View Aspirin Review and Aspirin Label ), ATORVASTATIN (ATORVASTATIN) (View Atorvastatin (atorvastatin) Review and Atorvastatin (atorvastatin) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

4566331-X | Abdominal Pain, Epistaxis, Rectal Haemorrhage
Adverse event was reported on Jan 14, 2005 by a Female patient taking Persantin (View Usage) (Dosage: 200 Mg (daily), Po) was diagnosed with cerebrovascular accident prophylaxis and. Location: , 76 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), epistaxis, rectal haemorrhage. During the same period patient was treated with PERINDOPRIL (PERINDOPRIL) (View Perindopril (perindopril) Review and Perindopril (perindopril) Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), BENDROFLUAZIDE (BENDROFLUMETHIAZIDE) (View Bendrofluazide (bendroflumethiazide) Review and Bendrofluazide (bendroflumethiazide) Label ), CLOPIDOGREL (CLLOPIDOGREL) (View Clopidogrel (cllopidogrel) Review and Clopidogrel (cllopidogrel) Label ).

4550118-8 | Interstitial Lung Disease, Off Label Use
on Dec 27, 2004 Male patient from , 72 years of age, was diagnosed with hypertension and was treated with Persantin (View Usage). After Persantin was administered, patient had the following side effects: interstitial lung disease, off label use. Persantin dosage: 37.5 Mg (12.5 Mg). During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), BEZAFIBRATE (BEZAFIBRATE) (TA) (View Bezafibrate (bezafibrate) (ta) Review and Bezafibrate (bezafibrate) (ta) Label ), ADALAT CR (NIFEDIPINE) (TAD) (View Adalat-cr (nifedipine) (tad) Review and Adalat-cr (nifedipine) (tad) Label ).

4545215-7 | Interstitial Lung Disease, Off Label Use
on Dec 16, 2004 Male patient from , 72 years of age, was diagnosed with hypertension and was treated with Persantin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, off label use. Persantin dosage: 37.5 Mg Po. During the same period patient was treated with DIOVAN (Po) (View Diovan Review and Diovan Label ), BEZAFIBRATE (BEZAFIBRATE) (TA) (View Bezafibrate (bezafibrate) (ta) Review and Bezafibrate (bezafibrate) (ta) Label ), ADALAT CR (NIFEDIPINE) (TAD) (View Adalat-cr (nifedipine) (tad) Review and Adalat-cr (nifedipine) (tad) Label ).